CCMU
GRCL

Cheyne Capital Management (UK)’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Cheyne Capital Management (UK)’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-98,120
Closed -$226K – 57
2022
Q4 		$226K Buy
+98,120
New +$226K 0.39% 54